FDA Authorizes Merck’s Anti-Coronavirus Pill, a Second Treatment Option In the NewsArticles of InterestPolicy AreasBrain InjuryChildren's ServicesCriminal JusticeIntellectual & Developmental DisabilitiesMedical RehabMental HealthPhysical Disabilities & AgingSubstance Use Disorder Dec 23, 2021 0 0